Blackrock Neurotech
Blackrock Neurotech62About
What does Blackrock Neurotech do?
Blackrock Neurotech develops innovative brain technology, specifically implantable neural devices, that empower individuals with paralysis and other neurological disorders. Their platform enables BCI Pioneers to regain functions like communication and movement, with users achieving significant typing and decoding speeds. The company serves both patients seeking to improve their lives and over 1000 research institutions worldwide.
What is Blackrock Neurotech's valuation?
StartupHub estimates Blackrock Neurotech's effective valuation at $277.8M (range $194.4M to $361.1M, 31% confidence), based on comparable companies in the sector.
How much funding has Blackrock Neurotech raised?
Blackrock Neurotech has raised a total of $210M in funding. The most recent round on record is Series A.
Where is Blackrock Neurotech headquartered?
Blackrock Neurotech is headquartered in Salt Lake City, United States.
When was Blackrock Neurotech founded?
Blackrock Neurotech was founded in 2008.
What industry does Blackrock Neurotech operate in?
Blackrock Neurotech operates in Neurotech & HCI, Biotech & Longevity, Physical AI, HealthTech, Medical Devices, Brain-Computer Interface.
How many employees does Blackrock Neurotech have?
Blackrock Neurotech has approximately 184 people on record.
No comments yet. Be the first to share your take.